GENE logo

GENE
Genetic Technologies Ltd.

20,005
Mkt Cap
$3.71M
Volume
22,667.00
52W High
$0.765
52W Low
$0.765
PE Ratio
-0.55
GENE Fundamentals
Price
$0.765
Prev Close
$0.78
Open
$0.79
50D MA
$0.765
Beta
0.17
Avg. Volume
0.00
P/B
-2.76
Loading...
Loading...
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Fitzroy, Australia.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Genetic Technologies Ltd. - ADR?
What is the 52-week high for Genetic Technologies Ltd. - ADR?
What is the 52-week low for Genetic Technologies Ltd. - ADR?
What is Genetic Technologies Ltd. - ADR stock price today?
What was Genetic Technologies Ltd. - ADR stock price yesterday?
What is the PE ratio of Genetic Technologies Ltd. - ADR?
What is the Price-to-Book ratio of Genetic Technologies Ltd. - ADR?
What is the 50-day moving average of Genetic Technologies Ltd. - ADR?

Latest GENE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.